Feasibility and clinical value of CT-guided (125)I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.

about

Feasibility and clinical value of CT-guided (125)I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.

Item

http://www.wikidata.org/entity/Q49691413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Feasibility and clinical value ...... rst-line chemotherapy failure.

@en

Feasibility and clinical value of CT-guided

@nl

type

Item

label

Feasibility and clinical value ...... rst-line chemotherapy failure.

@en

Feasibility and clinical value of CT-guided

@nl

prefLabel

Feasibility and clinical value ...... rst-line chemotherapy failure.

@en

Feasibility and clinical value of CT-guided

@nl

P1476

Feasibility and clinical value ...... rst-line chemotherapy failure.

@en

P2093

Fei Gao

http://www.w3.org/2001/XMLSchema#string

Fujun Zhang

http://www.w3.org/2001/XMLSchema#string

Huzhen Yan

http://www.w3.org/2001/XMLSchema#string

Tao Zhang

http://www.w3.org/2001/XMLSchema#string

Yanling Zhang

http://www.w3.org/2001/XMLSchema#string

Zhanwang Xiang

http://www.w3.org/2001/XMLSchema#string

Zhihui Zhong

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Mo

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical management and minimally invasive approaches for the treatment of metastatic sarcoma

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.

Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection.

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

Early complications of high-dose-rate brachytherapy in soft tissue sarcoma: a comparison with traditional external-beam radiotherapy

Radiation dose profile in 125I brachytherapy: an 8-year review.

P2888

s00330-017-5036-0

P31

scholarly article

P356

10.1007/S00330-017-5036-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28956119

http://www.w3.org/2001/XMLSchema#string

P921

brachytherapy